Abstract:Growth Hormone Releasing Hormone (GHRH) is one of the most important hormones in life. Because of its potential clinical importance, its short half-life, and its expensive chemical synthesis, an analog of hGHRH with a prolonged half-life and better activity has been studied for clinical application, especially for the treatment of muscle wasting, type II diabetes, or sleep disorders. The Pro–Pro–hGHRH(1–44) peptide has better activity. The fusion partner gene with 127 amino acid residues of the C-terminus from l-asparaginase was recombined with asp-pro–pro–hGHRH(1–44) gene synthesized by PCR method to form a fusion protein with the unique acid labile linker Asp–Pro. The recombinant protein was expressed to high levels in Escherichia coli BL21 (DE3). The Pro–Pro–hGHRH(1–44) peptide was purified to homogeneity by means of cell disruption, washing, ethanol precipitation, acid hydrolysis, and SP-Sephadex C-25, and Sephadex G-25 column chromatography. The fold of the purification was about 88 times and the yield was 1.1% of the total protein weight of the inclusion body. The peptide molecular mass of 5235.25Da was determined by ESI mass spectroscopy. Its purity was determined by SDS–PAGE. In the study of the activity, we measured GH release of rat pituitary by using the antiserum kit against human GH. The peptide doses of 0.01, 0.1, 1.0, 7.72, and 20.9μg/ml used, respectively, released the GH values of 0.1±0.1, 12.5±7.3, 16.6±5.8, 49.8±7.6, and 79.5±5.7ng/ml whereas their blank controls, respectively, were 0.5±0.8, 4.1±2.6, 3.1±3.1, 4.7±1.8, and 1.2±0.3ng/ml. The activity results of all dose groups except 0.01μg/ml Pro–Pro–hGHRH(1–44) group and hGHRH(1–40) group showed that there were significant differences between GH released by the peptide and that by its blank control. With the increase of dosage, the differences were more significant. hGHRH(1–40) showed no measured GH release when the dose was up to 2μg/ml. The activity results show that the Pro–Pro–hGHRH(1–44) peptide is a potential GH releasing analog.

Spiro(indoline-3,4'-piperidine) growth hormone secretagogues as ghrelin mimetics

Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues

In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays

In Vivo Bioassay of Recombinant Human Growth Hormone Synthesized Inb. Moripupae

Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-agonists but not allosteric regulators for activation of the G protein Galpha(o1) by the Ghrelin receptor

Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.

Structure and function relationships of three novel hGHRH-GGC analogs

Growth hormone secretagogues and their structure-activity relationship

A Facile Synthesis of the Spiroindoline-Based Growth Hormone Secretagogue,mk-677

Study on the Constructions and Activities of Three Novel Hghrh Analogs with N-terminal Prolyl Modulation+

A Novel Hghrh Analog and Its Comparative Activity

The Efficacy of Enhanced Growth by Ectopic Expression of Ghrelin and Its Variants Using Injectable Myogenic Vectors

Production and enhanced biological activity of a novel GHRH analog, hGHRH with an N-terminal Pro-Pro extension.

Construction and Activity of A Novel Ghrh Analog, Pro-,Pro-Hghrh(1-44)-Gly-Gly-Cys

Synthetic analogs of growth hormone-releasing factor with antagonistic activity in vitro.

Structural Basis for Activation of the Growth Hormone-Releasing Hormone Receptor.

Recombination and Comparable Activity of A Novel Hghrh Analogs,Pro-hGHRH(1-44)-Gly-Gly-Cys

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR)

Ghrelin and its biological effects on pigs.

Identification of a Putative β-Arrestin Superagonist of the Growth Hormone Secretagogue Receptor (GHSR)